Pusic I, Miklos D, Cutler C, et al. Ibrutinib for chronic graft-versus-host disease after failure of frontline corticosteroids: results of a multicenter open-label phase 2-study. EHA 2017, S492.
THEMIS2-expressie verbetert voorspelling time-to-first-treatment bij CLL
jan 2024 | Leukemie